Luke Thomas Power - 17 Jun 2025 Form 3 Insider Report for Caris Life Sciences, Inc.

Role
Officer
Signature
/s/ J. Russel Denton, Attorney-in-Fact
Issuer symbol
CAI on Nasdaq
Transactions as of
17 Jun 2025
Net transactions value
$0
Form type
3
Filing time
17 Jun 2025, 21:35:07 UTC
Next filing
23 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Power Luke Thomas Officer C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING /s/ J. Russel Denton, Attorney-in-Fact 17 Jun 2025 0002072013

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CAI Common Stock 250 17 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CAI Stock Option 17 Jun 2025 Common Stock 24,750 $2.44 Direct F1
holding CAI Stock Option 17 Jun 2025 Common Stock 37,500 $2.44 Direct F1
holding CAI Stock Option 17 Jun 2025 Common Stock 10,000 $8.00 Direct F1
holding CAI Stock Option 17 Jun 2025 Common Stock 12,500 $8.00 Direct F2
holding CAI Stock Option 17 Jun 2025 Common Stock 6,250 $12.84 Direct F3
holding CAI Stock Option 17 Jun 2025 Common Stock 5,031 $12.84 Direct F4
holding CAI Stock Option 17 Jun 2025 Common Stock 62,500 $16.20 Direct F5
holding CAI Stock Option 17 Jun 2025 Common Stock 62,500 $16.20 Direct F6
holding CAI Stock Option 17 Jun 2025 Common Stock 249,999 $16.20 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested and exercisable.
F2 The stock option vests in five substantially equal annual installments beginning on November 19, 2021.
F3 The stock option vests in five substantially equal annual installments beginning on May 20, 2022.
F4 The stock option vests in five substantially equal annual installments beginning on September 24, 2022.
F5 The stock option vests in five substantially equal annual installments beginning on August 11, 2022.
F6 The stock option vests in five substantially equal annual installments beginning on November 9, 2023.
F7 The stock option vests in five substantially equal annual installments beginning on May 17, 2024.

Remarks:

Senior Vice President, Chief Financial Officer, and Chief Accounting Officer. Exhibit 24 - Power of Attorney.